BS-HH-002

N/A

Report date: 2024/05/17 20:00:39
NME

Base Information

Drug NameBS-HH-002
Drug Alias NameBS-HH-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transduction pathway inhibitorsApoptosis stimulants
TargetsNot applicable
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBensen Pharmaceutical Corp Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBensen Pharmaceutical Corp Ltd
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A